Clinical Trial Update: The Effect of Melatonin on Cognitive Function in Patients Diagnosed With Mild Cognitive Impairment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether melatonin improves cognitive function in people with Mild Cognitive Impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Assaf-Harofeh Medical Center | Conditions: Mild Cognitive Impairment (MCI) | Phase 2 | Status: UNKNOWN